Warrenville, Illinois Clinical Trials

A listing of Warrenville, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

This phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trametinib works and compares it to initial treatment with dabrafenib and trametinib followed by ipilimumab and nivolumab in treating patients with stage III-IV melanoma that contains a mutation known as BRAFV600 and cannot …

ipilimumab
HIV Infection
dabrafenib
mitomycin
absolute neutrophil count
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 426 views
  • 15 Sep, 2021
  • +661 other locations
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer the DECREASE Study

This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing …

Rush - Copley Medical Center
 (5.1 away) Contact site
  • 11 views
  • 15 Sep, 2021
  • +367 other locations
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

This phase III trial compares whether the addition of pembrolizumab to radiation therapy is more effective than radiation therapy alone in reducing the risk of cancer coming back (recurrence) in patients with newly diagnosed stage I-II endometrial cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune …

Northwestern Medicine Cancer Center Warrenville
 (1.4 away) Contact site
  • 1 views
  • 15 Sep, 2021
  • +143 other locations
A Feasibility Study on Ultrafiltration and Blood Volume Measurements

The objective of this feasibility study is to characterize the performance of CHF Solutions' ultrafiltration system, the Aquadex FlexFlow System with the hematocrit (HCT) feature in conjunction with Daxor's blood volume analyzer (BVA-100). Monitor blood volume changes during UF therapy as a potential mean to guide the removal of fluid …

chest x-ray
fluid overload
heart failure
orthopnea
acute decompensated heart failure
Edward Hospital Center for Advanced Heart Failure
 (5.4 away) Contact site
  • 3 views
  • 15 Sep, 2021
  • 1 location
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal …

cancer
metastasis
whole-brain radiotherapy
brain tumor
stereotactic radiosurgery
Loyola University Medical Center
 (18.2 away) Contact site
  • 98 views
  • 15 Sep, 2021
  • +71 other locations
Testing the Combination of Olaparib and Durvalumab Cediranib and Durvalumab Olaparib and Capivasertib and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone and Olaparib Alone

This phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating patients with endometrial cancer that has come back (recurrent) or does not respond to treatment (refractory). Olaparib, cediranib, and capivasertib may stop the growth of …

bevacizumab
levonorgestrel
luteinizing hormone
serous adenocarcinoma
maintenance therapy
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 76 views
  • 15 Sep, 2021
  • +504 other locations
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as gemcitabine, cisplatin, fluorouracil and mitomycin-C, work in different …

corticosteroids
HIV Infection
bcg vaccine
hepatitis b
bladder cancer
Northwestern Medicine Cancer Center Warrenville
 (1.4 away) Contact site
  • 37 views
  • 15 Sep, 2021
  • +182 other locations
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that have spread to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. …

ipilimumab
corticosteroids
squamous cell carcinoma
kinase inhibitor
tubal ligation
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 191 views
  • 15 Sep, 2021
  • +476 other locations
Lenalidomide and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them …

arrhythmia
immunoglobulins
lytic bone lesion
tubal ligation
erythropoietin
Northwestern Medicine Cancer Center Warrenville
 (1.4 away) Contact site
  • 15 views
  • 15 Sep, 2021
  • +488 other locations
Testing The Addition of a New Anti-cancer Drug Venetoclax to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated Older Patients With Chronic Lymphocytic Leukemia

This phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia who have not received previous treatment. The addition of venetoclax to the usual treatment might prevent chronic lymphocytic leukemia from returning. This trial also will …

flow cytometry
corticosteroids
immunoglobulin
lymphoid leukemia
obinutuzumab
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 382 views
  • 15 Sep, 2021
  • +740 other locations